Article Details

Defence's Proprietary Accum Technology Ready to License to Companies Developing ...

Retrieved on: 2024-11-30 11:05:28

Tags for this article:

Click the tags to see associated articles and topics

Defence's Proprietary Accum Technology Ready to License to Companies Developing .... View article details on hiswai:

Summary

The article discusses Defence Therapeutics Inc.'s plans to license its Accum® technology to boost the efficacy of Antibody Drug Conjugates (ADCs) in biotechnology, relating to tags like 'ADC' and 'biopharmaceutical'. It also details recent warrant offerings.

Article found on: www.newsfilecorp.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up